Evidence map›Paper›PMID 32352375›Full record

ArticleeLife2020

An advanced cell cycle tag toolbox reveals principles underlying temporal control of structure-selective nucleases.

Julia Bittmann, Rokas Grigaitis, Lorenzo Galanti, Silas Amarell, Florian Wilfling, Joao Matos, Boris Pfander

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Julia BittmannMax Planck Institute of Biochemistry, DNA Replication and Genome Integrity, Martinsried, Germany.ORCID 0000-0001-6527-7383
Rokas GrigaitisInstitute of Biochemistry, Eidgenössische Technische Hochschule, Zürich, Zürich, Switzerland.
Lorenzo GalantiMax Planck Institute of Biochemistry, DNA Replication and Genome Integrity, Martinsried, Germany.ORCID 0000-0003-2538-3581
Silas AmarellMax Planck Institute of Biochemistry, DNA Replication and Genome Integrity, Martinsried, Germany.
Florian WilflingMax Planck Institute of Biochemistry, Molecular Cell Biology, Martinsried, Germany.
Joao MatosInstitute of Biochemistry, Eidgenössische Technische Hochschule, Zürich, Zürich, Switzerland.ORCID 0000-0002-3754-3709
Boris PfanderMax Planck Institute of Biochemistry, DNA Replication and Genome Integrity, Martinsried, Germany.ORCID 0000-0003-2180-5054
Max Planck Institute of Biochemistry · DEBoard of the Swiss Federal Institutes of Technology · CH

Funding

Deutsche Forschungsgemeinschaft 213249687 - SFB 1064Deutsche Forschungsgemeinschaft PF794/3-1
6 · The paper itself

Abstract

Cell cycle tags allow to restrict target protein expression to specific cell cycle phases. Here, we present an advanced toolbox of cell cycle tag constructs in budding yeast with defined and compatible peak expression that allow comparison of protein functionality at different cell cycle phases. We apply this technology to the question of how and when Mus81-Mms4 and Yen1 nucleases act on DNA replication or recombination structures. Restriction of Mus81-Mms4 to M phase but not S phase allows a

Indexed as

Cell CycleDNA-Binding ProteinsDNA DamageEndonucleasesFlap EndonucleasesMitosisSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsS PhaseDNA-Binding ProteinsEndonucleasesFlap EndonucleasesSaccharomyces cerevisiae Proteinsbiochemistrycell cyclechemical biologychromosomesgene expressiongenome stabilityhomologous recombinationjoint molecule resolutionpost-translational modificationS. cerevisiae

Identifiers

PMID32352375
PMCPMC7220381
OpenAlexW3021338116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.